[1] THOM V,SCHMID S,GELDERBLOM M,et al.IL-17 production by CSF lymphocytes as a biomarker for cerebral vasculitis[J].Neurol Neuroimmunol Neuroinflamm,2016,3(2):e214.
[2] MA S,ZHONG D,CHEN H,et al.The immunomodulatory effect of bone marrow stromal cells(BMSCs) on interleukin(IL)-23/IL-17-mediated ischemic stroke in mice[J].J Neuroimmunol,2013,257(1/2):28.
[3] ABIDOV M,RAMAZANOV Z,SEIFULLA R,et al.The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat[J].Diabet Obes,2010,12(1):72.
[4] WANG L,LI Q,WANG L,et al.The role of Th17/IL-17 in the pathogenesis of primary nephrotic syndrome in children[J].Kidney Blood Press Res,2013,37(4/5):332.
[5] KEIJSERS RR,JOOSTEN I,VAN ERP PE,et al.Cellular sources of IL-17 in psoriasis:a paradigm shift?[J].Exp Dermatol,2014,23(11):799.
[6] YAO Z,FANSLOW WC,SELDIN MF,et al.Herpesvirus Saimiri encodes a new cytokine,IL-17,which binds to a novel cytokine receptor[J].J Immunol,2011,187(9):4392.
[7] CONTI HR,PETERSON AC,BRANE L,et al.Oral-resident natural Th17 cells and gammadelta T cells control opportunistic Candida albicans infections[J].Exp Med,2014,211(10):2075.
[8] KANG Z,WANG Z,ZEPP J,et al.Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells[J].Nat Neurosci,2013,16(10):1401.
[9] WANG C,WU L,BULEK K,et al.The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone Hsp90[J].Nat Immunol,2013,14(1):72.
[10] BULEK K,LIU C,SWAIDANI S,et al.The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation[J].Nat Immunol,2011,12(9):844.
[11] GU CF,WU L,LI XX.IL-17 family:cytokines,receptors and signaling[J].Cytokine,2013,64(2):477.
[12] WANG W,ZHOU A,ZHANG X,et al.Interleukin 17A promotes pneumococcal clearance by recruiting neutrophils and inducing apoptosis through a p38 mitogen-activated protein kinase-dependent mechanism in acute otitis media[J].Infect Immun,2014,82(6):2368.
[13] DE CIUCEIS C,ROSSINI C,TINCANIi A,et al.Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension[J].Blood Press,2016,19:1.
[14] SHUANG L,LI Z,CHEN F,CUI X,et al.Association between interleukin-17 gene polymorphisms and risk of coronary artery disease[J].Int J Clin Exp Pathol,2015,8(9):11653.
[15] ZHANG Q,GOU F,ZHANG Y,et al.Potassium channel changes of peripheral blood T-lymphocytes from Kazakh hypertensive patients in Northwest China and the inhibition effect towards potassium channels by telmisartan[J].Kardiol Pol,2016,74(5):476.
[16] MADHUR MS,LOB HE,MCCANN LA,et al.Interleukin-17 promotes angiotensin Ⅱ-induced hypertension and vascular dysfunction[J].Hypertension,2010,55(2):500.
[17] 刘振东,路方红,赵颖馨,等.原发性高血压患者动脉僵硬度与Th17细胞相关效应因子的关系[J].中国动脉硬化杂志,2012,20(1):57.
[18] REDDY MA,ZHANG E,NATARAJAN R.Epigenetic mechanisms in diabetic complications and metabolic memory[J].Diabetologia,2015,58(3):443.
[19] FRANCISCO CO,CATAI AM,MOURA-TONELLO SC,et al.Cytokine profile and lymphocyte subsets in type 2 diabetes[J].Braz J Med Biol Res,2016,49(4):e5062.
[20] CASTOLDI G,GALIMBERTI S,RIVA C,et al.Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes[J].Clin Sci(Lond),2007,113(2):103.
[21] PILEGGI GS,CLEMENCIO AD,MALARDO T,et al.New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro[J].BMC Biotechnol,2016,16(1):40.
[22] 楼旭丹,汪海东,陈芳,等.2型糖尿病大血管病变患者血清IL-17水平变化及意义[J].中国老年学杂志,2013,33(13):3024.
[23] BEKWELEM W,JENSEN PN,NORBY FL,et al.Carotid atherosclerosis and stroke in atrial fibrillation:the atherosclerosis risk in communities study[J].Stroke,2016,47(6):1643.
[24] AITt-OUFELLA H,SAGE AP,MALLAT Z,et al.Adaptive(T and B cells) immunity and control by dendritic cells in atherosclerosis[J].Circ Res,2014,114(10):1640.
[25] BUTCHER MJ,WU CI,WASEEM T,et al.CXCR6 regulates the recruitment of pro-inflammatory IL-17A-producing T cells into atherosclerotic aortas[J].Int Immunol,2016,28(5):255.
[26] KARBACH S,CROXFORD AL,OELZE M,et al.Interleukin 17 drives vascular inflammation,endothelial dysfunction,and arterial hypertension in psoriasis-like skin disease[J].Arterioscler Thromb Vasc Biol,2014,34(12):2658.
[27] CIMATO TR,PALKA BA,LANG JK,et al.LDL cholesterol modulates human CD34+ HSPCs through effects on proliferation and the IL-17 G-CSF axis[J].PLoS One,2013,8(8):e73861.
[28] GISTERA A,ROBERTSON AK,ANDERSSON J,et al.Transforming growth factor-β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway[J].Sci Transl Med,2013,5(196):196.
[29] MICHAEL DR,ASHLIN TG,DAVIES CS,et al.Differential regulation of macropinocytosis in macrophages by cytokines:implications for foam cell formation and atherosclerosis[J].Cytokine,2013,64(1):357.
[30] DOLL DN,BARR TL,SIMPKINS JW.CYTOKINES:their role in stroke and potential use as biomarkers and therapeutic targets[J].Aging Dis,2014,5(5):294.
[31] HUPPERT J,CLOSHEN D,CROXFORD A,et al.Cellular mechanisms of IL-17-induced blood-brain barrier disruption[J].Faseb J,2010,24(10):1023.
[32] ABADIER M,HAGHAYEGH JAHROMI N,CARDOSO ALVES L,et al.Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier[J].Eur J Immunol,2015,45(4):1043.
[33] LI Q,WANG Y,YU F,et al.Peripheral Th17/Treg imbalance in patients with atherosclerotic cerebral infarction[J].Int J Clin Exp Pathol,2013,6(6):1015.
[34] ZHANG J,MAO X,ZHOU T,et al.IL-17A contributes to brain ischemia reperfusion injury through calpain-TRPC6 pathway in mice[J].Neuroscience,2014,274:419.
[35] 刘贵香,姚平波,张平,等.急性脑梗死患者外周血Th17细胞与调节性T细胞的表达水平与预后的关系[J].广东医学杂志,2014,35(7):1027.
[36] ZHENG Y,ZHONG D,CHEN H,et al.Pivotal role of cerebral interleukin-23 during immunologic injury in delayed cerebral ischemia in mice[J].Neurosci,2015,290:321.
[37] ERBELl C,DENGLER TJ,WANGLER S,et al.Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability[J].Basic Res Cardiol,2011,106(1):125.
[38] CHENG X,TALEB S,WANG J,et al.Inhibition of IL-17A in atherosclerosis[J].Atherosclerosis,2011,215(2):471.
[39] FANG Y,SNG H,YUAN N,et al.Ethanolic extract of propolis inhibits atherosclerosis in ApoE-knockout mice[J].Lipids Health Dis,2013,12(1):123.